Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ghaleb A. Al Mekhlafi"'
Autor:
Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, Mashan L. Abdullah, Haya A. Aljami, Hanan H. Balkhy, Majed Al Jeraisy, Yasser Mandourah, Sameera AlJohani, Shmeylan Al Harbi, Hani A. Aziz Jokhdar, Ahmad M. Deeb, Ziad A. Memish, Jesna Jose, Sameeh Ghazal, Sarah Al Faraj, Ghaleb A. Al Mekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Frederick G. Hayden, Robert A. Fowler, Badriah M. AlMutairi, Abdulaziz Al-Dawood, Naif Khalaf Alharbi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Animal and human data indicate variable effects of interferons in treating coronavirus infections according to inflammatory status and timing of therapy. In this sub-study of the MIRACLE trial (MERS-CoV Infection Treated with a Combination o
Externí odkaz:
https://doaj.org/article/e5a94615be554d5c80e9bfc21370cdd0
Autor:
Jesna Jose, Hasan M. Al-Dorzi, Awad Al-Omari, Yasser Mandourah, Fahad Al-Hameed, Musharaf Sadat, Eman Al Qasim, Basem Alraddadi, Abdulrahman Al Harthy, Ghaleb A. Al Mekhlafi, Abdullah Almotairi, Kasim Al Khatib, Ahmed Abdulmomen, Ismael Qushmaq, Anees A. Sindi, Ahmed Mady, Othman Solaiman, Rajaa Al-Raddadi, Khalid Maghrabi, Ahmed Ragab, Ayman Kharaba, Sarah Shalhoub, Abdulsalam M. Al-Aithan, Gajendra K. Vishwakarma, Atanu Bhattacharjee, Yaseen M. Arabi, The Saudi Critical Care Trials Group
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Diabetes is a risk factor for infection with coronaviruses. This study describes the demographic, clinical data, and outcomes of critically ill patients with diabetes and Middle East Respiratory Syndrome (MERS). Methods This retro
Externí odkaz:
https://doaj.org/article/4775d74f15a441e5bda3c9bf80d0294b
Autor:
Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, Hani A. Aziz Jokhdar, Adel Alothman, Hanan H. Balkhy, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Ziad A. Memish, Sameeh Ghazal, Sarah Al Faraj, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Al Mekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Abdullah Almotairi, Ali Al Bshabshe, Ayman Kharaba, Jesna Jose, Abdulrahman Al Harthy, Mohammed Al Sulaiman, Ahmed Mady, Robert A. Fowler, Frederick G. Hayden, Abdulaziz Al-Dawood, Mohamed Abdelzaher, Wail Bajhmom, Mohamed A. Hussein, and the Saudi Critical Care Trials group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract The MIRACLE trial (MERS-CoV Infection tReated with A Combination of Lopinavir/ritonavir and intErferon-β1b) investigates the efficacy of a combination therapy of lopinavir/ritonavir and recombinant interferon-β1b provided with standard sup
Externí odkaz:
https://doaj.org/article/98b352d6164e45ae9eb5230477b9fe36
Autor:
Yaseen Arabi, Hasan M Al-Dorzi, Omar Aldibaasi, Musharaf Sadat, Jesna Jose, Dina Muharib, Haifa Algethamy, Abdulrahman A Al-Fares, Fahad Al-Hameed, Ahmed Mady, Ayman Kharaba, Ali Al Bshabshe, Khalid Maghrabi, Khalid Al Ghamdi, Ghulam Rasool, Adnan AlGhamdi, Ghaleb A Al Mekhlafi, Jamal Chalabi, Haifa AlHumedi, Maram Hasan Sakkijha, Norah Khaled Alamrey, Amjad Al Askar, Rabeah Hamad Alhutail, Kaouthar Sifaoui, Rakan Alqahtani, Ahmed Qureshi, Mohammed Moneer Hejazi, Hatim Arishi, Samah Al Qahtani, Amro Mohammed Ghazi, Saleh T Baaziz, Abeer Othman Azhar, Sara Fahad Azhar, Mohammed AlAqeely, Ohoud AlOrabi, Alia Al-Muatawa, Maha AlOtaibi, Madiha AlGhannem, Mohammed Almaani, Sarah Fadel Buabbas, Wadiah Alawi M Al-Filfil, Mohammed S AlShahrani, Joel Starkopf, Jean - Charles Preiser, Anders Perner, Jumana Hani AlMubarak, Wafa Mansoor Hazem, Talal Ibrahim, Abdulaziz Al-Dawood
Background The optimal amount and timing of protein intake in critically ill patients are unknown. REPLENISH (Replacing Protein via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients) trial evaluates whether supplemental enteral prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a36a7126696e37e87e5accf4d4acbb5b
https://doi.org/10.21203/rs.3.rs-2601260/v1
https://doi.org/10.21203/rs.3.rs-2601260/v1
Autor:
null Faizah Alotaibi, null Naif Khalaf Alharbi, null Lindsey B. Rosen, null Ayed Y. Asiri, null Abdullah M. Assiri, null Hanan H. Balkhy, null Majed Al Jeraisy, null Yasser Mandourah, null Sameera AlJohani, null Shmeylan Al Harbi, null Hani A. Aziz Jokhdar, null Ahmad M. Deeb, null Ziad A. Memish, null Jesna Jose, null Sameeh Ghazal, null Sarah Al Faraj, null Ghaleb A. Al Mekhlafi, null Nisreen Murad Sherbeeni, null Fatehi Elnour Elzein, null Badriah M. AlMutairi, null Abdulaziz Al‐Dawood, null Mashan L. Abdullah, null Tlili Barhoumi, null Mohammed W. Alenazi, null Abdulrahman Almasood, null Steven M. Holland, null Yaseen M. Arabi, null the Saudi Critical Care Trials Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee16a1656f989e6e9eef742a95868103
https://doi.org/10.1111/irv.13116/v2/response1
https://doi.org/10.1111/irv.13116/v2/response1
Autor:
Hani Tamim, Adnan Alghamdi, Abdulaziz Al-Dawood, Lara Afesh, Musharaf Sadat, Maram Sakkijha, Raghad Malebari, Ghulam Rasool, Fahad Al-Hameed, Rabeah Hamad Alhutail, Yaseen M. Arabi, Ghaleb A. Al Mekhlafi, Hasan M. Al-Dorzi, Norah Khalid Alamrey
Publikováno v:
Clinical Nutrition ESPEN. 44:166-172
Summary Background and aims The optimal amount of protein intake in critically ill patients is unclear. The objective of this pilot trial is to assess the feasibility of a large randomized controlled trial testing higher versus lower protein intake i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0fd8ff33e6af3dc1e4c8d8235accb70
https://doi.org/10.1016/j.clnesp.2021.05.008
https://doi.org/10.1016/j.clnesp.2021.05.008
Autor:
Fahad Al-Hameed, Eman Al Qasim, Kasim Al Khatib, Hasan M. Al-Dorzi, Ahmed Ragab, Atanu Bhattacharjee, Ayman Kharaba, Abdullah Almotairi, Gajendra K. Vishwakarma, Yaseen M. Arabi, Yasser Mandourah, Othman Solaiman, Abdulsalam M. Al-Aithan, Anees Sindi, Khalid Maghrabi, Basem Alraddadi, Awad Al-Omari, Ismael Qushmaq, Abdulrahman Al Harthy, Ghaleb A. Al Mekhlafi, Rajaa Al-Raddadi, Jesna Jose, Ahmed Abdulmomen, Ahmed Mady, Sarah Shalhoub, Musharaf Sadat
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
BackgroundDiabetes is a risk factor for infection with coronaviruses. This study describes the demographic, clinical data, and outcomes of critically ill patients with diabetes and Middle East Respiratory Syndrome (MERS).MethodsThis retrospective coh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::504438187dec6943aa6f8ab3e2133fda
https://doaj.org/article/4775d74f15a441e5bda3c9bf80d0294b
https://doaj.org/article/4775d74f15a441e5bda3c9bf80d0294b
Autor:
Jesna Jose, Al-Dorzi, Hasan M., Al-Omari, Awad, Mandourah, Yasser, Al-Hameed, Fahad, Musharaf Sadat, Qasim, Eman Al, Alraddadi, Basem, Abdulrahman Al Harthy, Ghaleb A. Al Mekhlafi, Almotairi, Abdullah, Khatib, Kasim Al, Abdulmomen, Ahmed, Qushmaq, Ismael, Anees A. Sindi, Mady, Ahmed, Solaiman, Othman, Rajaa Al-Raddadi, Maghrabi, Khalid, Ragab, Ahmed, Kharaba, Ayman, Shalhoub, Sarah, Abdulsalam M. Al-Aithan, Gajendra K. Vishwakarma, Atanu Bhattacharjee, Arabi, Yaseen M.
Additional file 1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f86249d8a5fd5c985d7cf0ac03ad48
Autor:
Jesna Jose, Hasan Al-Dorzi, Awad Al-Omari, Yasser Mandourah, Fahad Al-Hameed, Musharaf Sadat, Eman Al-Qasim, Basem Alraddadi, Abdulrahman Al Harthy, Ghaleb A Al Mekhlafi, Abdullah Almotairi, Kasim Al Khatib, Ahmed Abdulmomen, Ismael Qushmaq, Anees Sindi, Ahmed Mady, Othman Solaiman, Rajaa Al-Raddadi, Khaled Maghrabi, Ahmed Rajab, Ayman Kharaba, Sara Shalhoub, Abdulsalam M Al-Aithan, Gajendra K Vishwakarma, Atanu Bhattacharjee, Yaseen Arabi
Background: Diabetes is a risk factor for infection with coronaviruses. This study describes the demographic, clinical data and outcomes of critically ill patients with diabetes who developed Middle East Respiratory Syndrome (MERS).Methods: This retr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b28463c28832948f65cafb35b40fce11
https://doi.org/10.21203/rs.3.rs-57988/v1
https://doi.org/10.21203/rs.3.rs-57988/v1
Autor:
Laura Merson, Frederick G. Hayden, Yasser Mandourah, Fahad Al-Hameed, Awad Al-Omari, Ghaleb A. Al Mekhlafi, Abdullah Almotairi, Ismael Qushmaq, Ahmed Ragab, Hanan H. Balkhy, Ayman Kharaba, Abdulaziz Al-Dawood, Othman Solaiman, Khalid Maghrabi, Abdulrahman Al Harthy, Eman Al Qasim, Basem Alraddadi, Abdulsalam M. Al-Aithan, Kasim Al Khatib, Anees Sindi, Jawaher Gramish, Robert A. Fowler, Rajaa Al-Raddadi, Jesna Jose, Ahmed Abdulmomen, Ahmed Mady, Sarah Shalhoub, Yaseen M. Arabi
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background The objective of this study was to evaluate the effect of ribavirin and recombinant interferon (RBV/rIFN) therapy on the outcomes of critically ill patients with Middle East respiratory syndrome (MERS), accounting for time-varying confound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b41fece4f075710f0fe0031526f843a